CLB
Core Laboratories NV
10.50$
-1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 44.7% | 38.2% | 32.5% | 35.5% | 35.6% | 28.6% | 29.2% | 32.5% | 36.6% | 38.1% | 38.4% | 36.8% | |
| 3.5% | 3.6% | 2.6% | 2.5% | 2.0% | 1.4% | 2.4% | 3.0% | 2.7% | 2.6% | 3.2% | 3.9% | |
| 3.5% | 3.6% | 2.6% | 2.5% | 2.0% | 1.4% | 2.4% | 3.0% | 2.7% | 2.6% | 3.2% | 3.9% | |
| 29.2% | 23.3% | 20.0% | 22.8% | 19.9% | 17.8% | 14.6% | 18.4% | 19.9% | 21.0% | 21.6% | 20.7% | |
| 6.4% | 6.5% | 5.9% | 5.7% | 7.0% | 6.5% | 6.7% | 7.8% | 10.5% | 12.2% | 10.1% | 9.3% | |
| 22.1% | 22.9% | 22.7% | 21.0% | 18.9% | 15.9% | 20.3% | 29.7% | 27.2% | 26.2% | 26.0% | 26.3% | |
| 24.3% | 28.5% | 31.2% | 30.6% | 33.8% | 27.6% | 17.5% | 17.1% | 17.2% | 17.0% | 16.8% | 18.1% | |
| 1.6% | 1.6% | 1.7% | 1.6% | 2.0% | 2.3% | 1.5% | 1.4% | 1.3% | 1.2% | 1.1% | 1.2% | |
| 86.1% | 103.8% | 72.9% | 74.6% | 75.2% | 76.5% | 86.7% | 72.3% | 67.3% | 60.8% | 56.3% | 53.4% | |
| 19.5% | 19.3% | 18.2% | 18.0% | 15.8% | 14.4% | 15.8% | 15.6% | 17.8% | 15.0% | 16.5% | 18.2% | |
| 1.6% | 2.3% | 2.7% | 2.9% | 1.6% | 1.5% | 2.0% | 2.1% | 2.0% | 1.7% | 1.8% | 2.0% | |
| 7.0% | 5.4% | 5.9% | 7.1% | 6.3% | 4.6% | 4.1% | 5.1% | 7.9% | 5.7% | 5.9% | 6.4% | |
| 52.7% | 68.9% | 37.8% | 38.8% | 44.7% | 39.4% | 45.6% | 32.5% | 29.8% | 27.8% | 21.4% | 18.9% | |
| 13.9% | -3.8% | 27.1% | 25.4% | 24.8% | 23.0% | 12.6% | 26.9% | 31.9% | 38.3% | 42.7% | 45.5% | |
| 61.6% | 35.1% | 32.8% | 29.7% | 24.1% | 20.7% | 8.9% | 11.8% | 14.9% | 20.6% | 25.5% | 29.6% | |
| 6.6% | 6.9% | 7.7% | 7.6% | 6.9% | 5.8% | 7.9% | 8.0% | 8.1% | 8.1% | 8.1% | 8.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.